HKSE:01501 (China)
Â
Ordinary Shares Class H
HK$
28.20
(-0.18%)
Aug 23
Business Description
Shanghai INT Medical Instruments Co Ltd
ISIN : CNE100003NH7
Share Class Description:
HKSE:01501: Ordinary Shares Class HCompare
Compare
Traded in other countries / regions
01501.Hong Kong IPO Date
2019-11-08Description
Shanghai INT Medical Instruments Co Ltd engages in the design and development of medical devices used in fields including peripheral intervention, neurological intervention, cardiovascular intervention or implantation and the design and development of equipment and moulds used for the production of medical devices. The company operates in the Chinese Mainland, Europe, The United States and Other countries and regions. The majority of revenue is from the Chinese Mainland.
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.58 | |||||
Equity-to-Asset | 0.81 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | 0.48 | |||||
Interest Coverage | 60.8 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 8.62 | |||||
Beneish M-Score | -2.01 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 23.5 | |||||
3-Year EBITDA Growth Rate | 8.4 | |||||
3-Year EPS without NRI Growth Rate | 5.4 | |||||
3-Year FCF Growth Rate | 4.2 | |||||
3-Year Book Growth Rate | 4.4 | |||||
Future 3-5Y EPS without NRI Growth Rate | 28.61 | |||||
Future 3-5Y Total Revenue Growth Rate | 30.08 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 50.27 | |||||
9-Day RSI | 50.91 | |||||
14-Day RSI | 52.16 | |||||
6-1 Month Momentum % | -1.25 | |||||
12-1 Month Momentum % | 6.14 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.29 | |||||
Quick Ratio | 1.88 | |||||
Cash Ratio | 1.37 | |||||
Days Inventory | 168.21 | |||||
Days Sales Outstanding | 38.9 | |||||
Days Payable | 37.81 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.06 | |||||
Dividend Payout Ratio | 0.27 | |||||
3-Year Dividend Growth Rate | 7.8 | |||||
Forward Dividend Yield % | 1.06 | |||||
5-Year Yield-on-Cost % | 1.06 | |||||
3-Year Average Share Buyback Ratio | -0.8 | |||||
Shareholder Yield % | -0.51 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 60.13 | |||||
Operating Margin % | 22.86 | |||||
Net Margin % | 21.89 | |||||
FCF Margin % | -6.64 | |||||
ROE % | 11.05 | |||||
ROA % | 9 | |||||
ROIC % | 12.04 | |||||
ROC (Joel Greenblatt) % | 23.59 | |||||
ROCE % | 12.01 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 25.52 | |||||
Forward PE Ratio | 22.2 | |||||
PE Ratio without NRI | 26.28 | |||||
Price-to-Owner-Earnings | 82.22 | |||||
PEG Ratio | 1.7 | |||||
PS Ratio | 5.51 | |||||
PB Ratio | 2.66 | |||||
Price-to-Tangible-Book | 3.09 | |||||
Price-to-Operating-Cash-Flow | 24.78 | |||||
EV-to-EBIT | 21.02 | |||||
EV-to-Forward-EBIT | 19.47 | |||||
EV-to-EBITDA | 21.02 | |||||
EV-to-Revenue | 5.23 | |||||
EV-to-Forward-Revenue | 4.14 | |||||
EV-to-FCF | -78.75 | |||||
Price-to-Projected-FCF | 13.06 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.83 | |||||
Price-to-Graham-Number | 1.98 | |||||
Price-to-Net-Current-Asset-Value | 12.76 | |||||
Price-to-Net-Cash | 80.57 | |||||
Earnings Yield (Greenblatt) % | 4.76 | |||||
FCF Yield % | -1.17 | |||||
Forward Rate of Return (Yacktman) % | 13.58 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanghai INT Medical Instruments Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 874.161 | ||
EPS (TTM) (HK$) | 1.105 | ||
Beta | 0.28 | ||
Volatility % | 11.73 | ||
14-Day RSI | 52.16 | ||
14-Day ATR (HK$) | 0.583831 | ||
20-Day SMA (HK$) | 28.2225 | ||
12-1 Month Momentum % | 6.14 | ||
52-Week Range (HK$) | 24.65 - 29.4 | ||
Shares Outstanding (Mil) | 175.2 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Shanghai INT Medical Instruments Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Shanghai INT Medical Instruments Co Ltd Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Shanghai INT Medical Instruments Co Ltd Frequently Asked Questions
What is Shanghai INT Medical Instruments Co Ltd(HKSE:01501)'s stock price today?
The current price of HKSE:01501 is HK$28.20. The 52 week high of HKSE:01501 is HK$29.40 and 52 week low is HK$24.65.
When is next earnings date of Shanghai INT Medical Instruments Co Ltd(HKSE:01501)?
The next earnings date of Shanghai INT Medical Instruments Co Ltd(HKSE:01501) is .
Does Shanghai INT Medical Instruments Co Ltd(HKSE:01501) pay dividends? If so, how much?
The Dividend Yield %  of Shanghai INT Medical Instruments Co Ltd(HKSE:01501) is 1.06% (As of Today), Highest Dividend Payout Ratio of Shanghai INT Medical Instruments Co Ltd(HKSE:01501) was 0.4. The lowest was 0.25. And the median was 0.32. The  Forward Dividend Yield % of Shanghai INT Medical Instruments Co Ltd(HKSE:01501) is 1.06%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |